(Q34987695)

English

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

Europe PubMed Central

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

0 references

Alzheimer's disease

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Joanne Rodda

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Shirlony Morgan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

19 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

International Psychogeriatrics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

813-824

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Prevalence of mental illness in a community nursing home.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

A description of agitation in a nursing home

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Mental disorders in the nursing home: another perspective.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Syndromic validity of apathy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Reliability, validity, and clinical correlates of apathy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Donepezil preserves cognition and global function in patients with severe Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Cholinergic deficits contribute to behavioral disturbance in patients with dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

The spectrum of behavioral changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Donepezil for the treatment of agitation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Antipsychotic drug use and mortality in older adults with dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Old and ill and still feeling well? Determinants of subjective well-being in >or=60 year olds: the role of the sense of coherence.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

21 January 2018

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610209990354

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1041610209990354

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538824%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34987695&oldid=1989037337"